Transdermal Drug Delivery Systems Market Report by Technology (Electroporation, Radiofrequency, Iontophoresis, Microporation, Thermal, Mechanical Arrays, Ultrasound, and Others), Application (Central Nervous System, Pain Management, Cardiovascular, Hormone, and Others), and Region 2025-2033
Market Report I 2025-09-01 I 139 Pages I IMARC Group
The global transdermal drug delivery systems market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. There are various factors that are driving the market, which include the growing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and neurological disorders, rising geriatric population, and increasing regulatory approvals.
Transdermal Drug Delivery Systems Market Trends:
Growing Prevalence of Chronic Diseases
People are becoming prone to chronic illnesses like diabetes, heart disease, rheumatoid arthritis, hypertension, and neurological disorders because of sedentary lifestyles and poor eating habits. Patients with these disorders need to take medication continuously for a longer time, which prompts them to look for reliable and convenient drug delivery options. For this, transdermal patches work best as they provide a steady flow of medication throughout time without requiring frequent use. The rising demand for non-invasive and easy-to-use alternative that can enhance patient compliance is impelling the transdermal drug delivery systems market growth. Patients using transdermal systems just need to apply a patch on a regular basis, which helps to lower the possibility of missing doses. People with chronic diseases are looking for solutions that offer enhanced convenience. According to the World Federation of Neurology, a groundbreaking new Global Burden of Disease (GBD) study shows that the number of people living with brain disease is expected to double by 2050.
Increasing Geriatric Population
The market is expanding as a result of the growing need for transdermal medication delivery systems among the aging population. People frequently acquire several chronic illnesses as they get older, including neurological disorders, diabetes, rheumatoid arthritis, and cardiovascular ailments. It might be difficult for elderly individuals to take these medications consistently over an extended period. The inability of the elderly to swallow medications is another typical problem. Transdermal drug delivery systems offer a convenient alternative because of their ability to bypass the need to take oral medications and provide a non-invasive method for sustained drug release. Furthermore, the growing need for simpler solutions among older individuals that lowers the burden of multiple daily doses is offering a favorable transdermal drug delivery systems market outlook. The World Health Organization (WHO) claims that the number of people aged 80 years or older is expected to reach 426 million by 2050.
Rising Regulatory Approvals
The National Medical Products Administration (NMPA) of China approved Luye Pharma Group's novel medicine, Rivastigmine Twice Weekly Transdermal Patch, on October 31, 2023, for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). Regulatory agencies are increasingly approving a broader range of transdermal products. This covers patches for a range of medicinal applications such as hormone replacement, pain relief, and even immunizations. Transdermal systems are becoming more widely available and varied, which is drawing in more patients and healthcare professionals.
Transdermal Drug Delivery Systems Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on technology and application.
Breakup by Technology:
- Electroporation
- Radiofrequency
- Iontophoresis
- Microporation
- Thermal
- Mechanical Arrays
- Ultrasound
- Others
Iontophoresis accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology. This includes electroporation, radiofrequency, iontophoresis, microporation, thermal, mechanical arrays, ultrasound, and others. According to the report, iontophoresis represented the largest segment.
Iontophoresis uses a small electric current to improve the diffusion of drugs via the skin. It is favored because of its ability to deliver precise dosages of medication while lowering side effects. It is especially useful for pain management, localized treatment, and systemic drug delivery, making it a leading choice in the transdermal market. It is non-invasive approach, which makes it a preferable alternative for patients who wish to avoid injections or oral medications, especially when long-term or frequent drug administration is required.
Breakup by Application:
- Central Nervous System
- Pain Management
- Cardiovascular
- Hormone
- Others
Pain management holds the largest share of the industry
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes central nervous system, pain management, cardiovascular, hormone, and others. According to the report, pain management accounts for the largest market share.
The rising focus on pain management among individuals is contributing to the market growth. Transdermal systems provide continuous and controlled release of pain-relieving medications, which is highly beneficial for chronic pain sufferers. This avoids the need for frequent dosing, making it more convenient for patients. Transdermal patches are a non-invasive alternative to oral medications and injections. Transdermal drug delivery systems for pain management provide an opioid-sparing alternative by delivering low and sustained doses that can manage pain effectively while reducing abuse potential.
Breakup by Region:
- North America
o United States
o Canada
- Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
- Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
- Latin America
o Brazil
o Mexico
o Others
- Middle East and Africa
North America leads the market, accounting for the largest transdermal drug delivery systems market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for transdermal drug delivery systems.
North America has a well-established healthcare system with access to cutting-edge medical technologies. Patients and healthcare providers in the region are more likely to adopt advanced drug delivery systems owing to the availability of infrastructure that supports their use and distribution. North America, particularly the United States, faces high prevalence of chronic diseases, requiring long-term and consistent medication management among individuals. Apart from this, the rising geriatric population in the region is bolstering the market growth. The number of Americans aged 65 and older is predicted to reach 80 million in 2040, as reported by the Urban Institute.
Competitive Landscape:
- The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the transdermal drug delivery systems industry include 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
- Top players are focusing on developing new transdermal systems for various therapeutic areas. Companies are also developing patches that deliver larger molecules including biologics. Moreover, key players are expanding the use of transdermal systems into mental health treatments. Many companies are entering into partnerships with research institutions, biotechnology firms, and other pharmaceutical companies to co-develop or license new transdermal technologies. They are also receiving funding and product approvals, which is strengthening the market growth. On 26 September 2023, Satio received funding of US$ 3.5 million by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services to develop SatioRx a novel at-home, remotely controllable transdermal drug delivery device.
Key Questions Answered in This Report:
- How has the global transdermal drug delivery systems market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global market?
- What is the impact of each driver, restraint, and opportunity on the global market?
- What are the key regional markets?
- Which countries represent the most attractive market?
- What is the breakup of the market based on the technology?
- Which is the most attractive technology in the market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the market?
- What is the competitive structure of the market?
- Who are the key players/companies in the global transdermal drug delivery systems market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Transdermal Drug Delivery Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Electroporation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Radiofrequency
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Iontophoresis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Microporation
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Thermal
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Mechanical Arrays
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Ultrasound
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Application
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pain Management
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cardiovascular
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Hormone
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 3M Company
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Acrux Limited
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Boehringer Ingelheim International GmbH
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Hisamitsu Pharmaceutical Co. Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Lavipharm S.A.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 LEAD CHEMICAL Co. Ltd.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Luye Pharma Group
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 Nutriband Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Viatris Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
?Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2024
Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2024
Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2024
Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2024
Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis
Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.